全文获取类型
收费全文 | 4064篇 |
免费 | 252篇 |
国内免费 | 78篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 200篇 |
妇产科学 | 57篇 |
基础医学 | 693篇 |
口腔科学 | 99篇 |
临床医学 | 473篇 |
内科学 | 891篇 |
皮肤病学 | 80篇 |
神经病学 | 245篇 |
特种医学 | 453篇 |
外科学 | 335篇 |
综合类 | 107篇 |
预防医学 | 257篇 |
眼科学 | 42篇 |
药学 | 258篇 |
2篇 | |
肿瘤学 | 165篇 |
出版年
2021年 | 26篇 |
2020年 | 27篇 |
2019年 | 37篇 |
2018年 | 59篇 |
2017年 | 47篇 |
2016年 | 52篇 |
2015年 | 58篇 |
2014年 | 78篇 |
2013年 | 117篇 |
2012年 | 95篇 |
2011年 | 112篇 |
2010年 | 126篇 |
2009年 | 121篇 |
2008年 | 127篇 |
2007年 | 166篇 |
2006年 | 130篇 |
2005年 | 124篇 |
2004年 | 97篇 |
2003年 | 81篇 |
2002年 | 105篇 |
2001年 | 104篇 |
2000年 | 113篇 |
1999年 | 90篇 |
1998年 | 164篇 |
1997年 | 184篇 |
1996年 | 158篇 |
1995年 | 126篇 |
1994年 | 131篇 |
1993年 | 112篇 |
1992年 | 81篇 |
1991年 | 107篇 |
1990年 | 84篇 |
1989年 | 104篇 |
1988年 | 87篇 |
1987年 | 105篇 |
1986年 | 107篇 |
1985年 | 98篇 |
1984年 | 77篇 |
1983年 | 51篇 |
1982年 | 67篇 |
1981年 | 48篇 |
1980年 | 39篇 |
1979年 | 33篇 |
1978年 | 30篇 |
1977年 | 30篇 |
1976年 | 35篇 |
1975年 | 31篇 |
1974年 | 21篇 |
1972年 | 22篇 |
1971年 | 28篇 |
排序方式: 共有4394条查询结果,搜索用时 0 毫秒
1.
JM Martín† L Calduch† C Monteagudo‡ I Molina† D Ramón† V Alonso† E Jordᆠ《Journal of the European Academy of Dermatology and Venereology》2006,20(4):428-431
Cutaneous plasmacytosis is a rare disorder characterized by a benign proliferation of mature plasma cells that appears as multiple dark-brown to purplish skin lesions, often associated with polyclonal hypergammaglobulinaemia. We present the case of a 55-year-old Caucasian man who suffered from a cutaneous plasmacytosis associated with two different carcinomas. Cutaneous plasmacytosis seems to be a reactive process because most cases reported are not associated with any apparent underlying disease. Nevertheless, because few reported cases were associated with malignancies, screening of additional neoplasms would be justified. 相似文献
2.
JM Vilanova J Figueras-Aloy J Roselló G Gómez E Gelpí R Jiménez 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(5):588-592
The aim of this study was to evaluate the cerebral synthesis of eicosanoids in the asphyctic newborn and to investigate the relation between the prostanoid profiles in cerebrospinal fluid (CSF) and the appearance and severity of hypoxic-ischaemic encephalopathy (HIE). Levels of 6-keto-PGF 1-α, TXB2 , PGE2 and PGF2-α in CSF were measured in 40 full term newborns during the first day of life. Thirty of these newborns had birth asphyxia and were divided into three groups: 10 without HIE, 12 with mild HIE and 8 with moderate-severe HIE. They were compared to a control group of 10 non-hypoxic newborns. Determinations of the metabolites in CSF were performed by RIA and expressed as pg/ml (mean ± SD). The CSF TXB2 (thromboxane A2 metabolite) in asphyxiated newborns was always higher than in the control group (28.12 ± 10.6), and related to the severity of HIE ( p = 0:005): without HIE (50.84 ± 16.4; p = 0:02), mild HIE (80.65 ± 12.64; p ± 0:01) and moderate-severe HIE (178.14 ± 20.5; p < 0:01). The CSF 6-keto-PGF 1-α (prostacyclin metabolite) in asphyxiated newborns was always higher than in the control group (80.55 ± 12.56), but indirectly related to the severity of HIE: without HIE (240.95 ± 28.12; p < 0:01), mild HIE (183.65 ± 30.1; p < 0:01) and moderate-severe HIE (140.55 ± 25.12; p < 0:01). In the moderate-severe HIE group, the increase in TXB2 was higher than the rise in 6-keto-PGF 1-α . 相似文献
3.
4.
5.
6.
7.
8.
9.
Occurrence of anti-C1q antibodies in IgA nephropathy 总被引:1,自引:0,他引:1
Gunnarsson I; Ronnelid J; Lundberg I; Jacobson S 《Nephrology, dialysis, transplantation》1997,12(11):2263-2268
Background: The pathogenic mechanisms and the antigens
involved in the establishment and progress of IgA nephropathy are unknown.
As antibodies against C1q have been reported to correlate with SLE
nephritis, we analysed the occurrence of these antibodies in IgA
nephropathy in order to investigate the possibility of pathogenetic
similarities in these renal disorders. Methods: The
occurrence of IgA- and IgG anti-C1q antibodies (anti-C1q) were determined
by ELISA in patients with IgA nephropathy (n=36) and SLE nephritis (n=37),
diseases both known to be associated with circulating immune complexes.
Levels of these antibodies were also determined in two other glomerular
diseases, i.e. idiopathic membranous glomerulo-nephritis (n=7) and minimal
change disease (n=2), in which circulating immune complexes are usually not
present, and in 40 healthy controls. Results: IgA
anti-C1q was observed in increased titres in 11/36 of the patients with IgA
nephropathy, in 2/37 of the patients with SLE nephritis (both with
proliferative disease) and in 1/9 of the patients with membranous and
minimal change disease (P<0.001). Increased titres of IgG anti-C1q
were observed in 1/36 of the patients with IgA nephropathy, in 17/37 of the
patients with SLE nephritis and in 0/9 of the patients with membranous and
minimal change disease (P<0.001). There were no correlations between
the levels of anti-C1q antibodies and clinical parameters such as degree of
proteinuria, haematuria, or renal function. Nor was there any correlation
to the concentration of C3a and the terminal complement complex (TCC) in
patients with IgA nephropathy. Conclusions: The
occurrence of anti-C1q antibodies in both IgA nephropathy and SLE
nephritis, albeit of different predominating isotypes, indicates the
possibility of a similar pathogenic mechanism involved in these renal
disorders. The occurrence of IgA anti-C1q antibodies in patients with IgA
nephropathy has to our knowledge not previously been reported. 相似文献
10.
G Lindstedt E Nystr?m P A Lundberg E Johansson R Eggertsen 《Scandinavian journal of primary health care》1992,10(3):192-197
In order to assess the diagnostic outcome of a screening for primary hyperparathyroidism (PHPT) in an elderly population, we determined ionized calcium in serum from 368 individuals participating in a health control at M?lnlycke Primary Care Centre (200 women, 168 men; age range 75-95 years); four-fifths of the individuals living in their homes, the remainder in homes for aged or nursing homes. Intact parathyroid hormone was determined in the samples with oinized calcium concentration greater than mean + 3SD of the truncated population sample, and these individuals were also recalled for another blood sample. Moderate hypercalcaemia, probably due to PHPT, was found in eight individuals (2% of the complete sample, 3% of the women), five having neuropsychiatric or neuromuscular symptoms consistent with PHPT. Surgical intervention is probably indicated in only a small proportion of elderly patients. We conclude that optimal benefits in relation to costs of screening for PHPT in old people will depend on the availability of a safe and simple pharmacological treatment that could determine any causal relationship between hypercalcaemia and symptoms. 相似文献